Pyroptosis-Related Gene Signature Is a Novel Prognostic Biomarker for Sarcoma Patients

<div>Immune infiltration landscape in Risk-H and Risk-L cohorts. (a) Relative percentages of 22 immune cell types in respective sarcoma samples. (b) Heat map of 22 immune cell types in The Cancer Genome Atlas sarcoma cohort.</div>

Disease Markers

fig5

Figure 5

Figure 5: Pyroptosis-Related Gene Signature Is a Novel Prognostic Biomarker for Sarcoma Patients 